New IVF test offers hope for greater pregnancy success rate
British scientists says chance of success could rise from 35 per cent to 80 per cent thanks to new test

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
British scientists say the success rate of IVF treatment could reach 80 per cent next year thanks to a new test that can pinpoint the most viable embryos.
Using current techniques, only about 35 per cent of IVF cycles result in a pregnancy.
The scientists, who were working at Oxford University, examined the behaviour of an embryo's mitochondria – the microscopic "power packs" inside cells. They found that some embryos have too much mitochondrial DNA, and that these will never develop into a baby, reports The Independent.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
New work has been commissioned to investigate what causes the excess, which is not yet understood.
Genetics professor Dagan Wells, who was involved in the research, told PA that by next year doctors could be using a test based on his team's discovery. If they can identify embryos with too much mitochondrial DNA, they will be able to avoid them and select embryos with a better chance of survival.
Wells said it can be a "brutal" experience for patients repeatedly having negative pregnancy tests. "Any test of the embryo that will result in a baby is therefore highly desirable," he said.
It comes as the biggest ever study of fertility treatment in the world found that women who undergo IVF are a third more likely to develop ovarian cancer.
University College London scientists said that the increased risk might be a result of underlying health problems in infertile women, but that the research also "leaves open the possibility" that the procedure itself might be to blame.
The Daily Telegraph points out that the risk is still small, however. "Just 15 in every 10,000 women developed ovarian cancer over the study period, compared with around 11 in 10,000 of the general population," it says. Last year nearly 50,000 women in the UK underwent IVF.
Both studies are being presented at the American Society for Reproductive Medicine (ASRM) conference held in Baltimore this week.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
What to know when filing a hurricane insurance claim
The Explainer A step-by-step to figure out what insurance will cover and what else you can do beyond filing a claim
By Becca Stanek Published
-
How fees impact your investment portfolio — and how to save on them
The Explainer Even seemingly small fees can take a big bite out of returns
By Becca Stanek Published
-
Enemy without
Cartoons
By The Week Staff Published
-
Good health news: seven surprising medical discoveries made in 2023
In Depth A fingerprint test for cancer, a menopause patch and the shocking impacts of body odour are just a few of the developments made this year
By The Week Staff Published
-
‘Three-parent babies’: the science behind groundbreaking new procedure
feature Aim is to prevent children from inheriting incurable mitochondrial illnesses
By The Week Staff Published
-
Five good-news cancer breakthroughs in 2023
In Depth Cancer-sniffing ants, ‘Bond villain’ DNA, and vaccine trials are just a few exciting developments in cancer research this year
By The Week Staff Published
-
mRNA technology and a vaccine for cancer
feature Cure is ‘in our grasp’ say the scientists behind the BioNTech Covid-19 jab
By The Week Staff Published
-
Do vegans live longer?
feature Plant-based lifestyles can drastically lower rates of some serious diseases
By Chas Newkey-Burden Published
-
Sanofi/GSK/Haleon: cancer fears prove hard to stomach
Business Briefing Shares of GlaxoSmithKline, Sanofi and the new GSK spin-off, Haleon, all fell sharply last week
By The Week Staff Published
-
The Week Unwrapped: Immunotherapy, unions and a house revival
podcast Can our immune systems help us fight cancer? Have unions finally cracked the tech sector? And is 90s house music making a comeback?
By The Week Staff Published
-
Neanderthal gene ‘caused up to a million Covid deaths’
Speed Read Genetic tweak found in one in six Britons means cells in the lungs are slower to launch defences
By The Week Staff Published